Image pharmaphorum Editor AZ-roundtable-interviews-2017 Video interview – Gunnar Brandrup-Wognsen Discussion with AstraZeneca’s Gunnar Brandrup-Wognsen AZ-roundtable-interviews-2017 Video interview – Professor Christopher Granger Discussion with a leading expert in the field, Professor Christopher Granger AZ-roundtable-biographies-2017 Roundtable participant biography – Professor Evangelos Giann... Head of the Chest Pain Unit and Private Ambulance at University Hospital Heidelberg, Germany AZ-roundtable-biographies-2017 Roundtable participant biography – Nick Hartshorne-Evans Chief Executive (Founder), Pumping Marvellous Foundation Load more results
AZ-roundtable-interviews-2017 Video interview – Gunnar Brandrup-Wognsen Discussion with AstraZeneca’s Gunnar Brandrup-Wognsen
AZ-roundtable-interviews-2017 Video interview – Professor Christopher Granger Discussion with a leading expert in the field, Professor Christopher Granger
AZ-roundtable-biographies-2017 Roundtable participant biography – Professor Evangelos Giann... Head of the Chest Pain Unit and Private Ambulance at University Hospital Heidelberg, Germany
AZ-roundtable-biographies-2017 Roundtable participant biography – Nick Hartshorne-Evans Chief Executive (Founder), Pumping Marvellous Foundation
News Novo Nordisk beefs up in oral obesity drugs with Vivtex deal Novo Nordisk is leaving no stone unturned in its bid to maintain its position in weight-loss therapies as it signs a $2.1bn alliance with Vivtex.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.